Heidi Critchfield
Primary Care · Locust Grove, VANPI 1710769138
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 154 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,458, more than ten times the $135 reported in 2023.
Across 154 payments — averaging $19.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$598
- AstraZeneca$408
- Pfizer$284
- Novo Nordisk$219
- Lilly USA, LLC$213
- Exact Sciences$185
- plus $1K from 15 others
What the payments were for
- Food & beverage$2,936100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 40 | $598 |
| AstraZeneca | 20 | $408 |
| Pfizer | 15 | $284 |
| Novo Nordisk | 10 | $219 |
| Lilly USA, LLC | 12 | $213 |
| Exact Sciences | 8 | $185 |
| Lundbeck LLC | 8 | $175 |
| Otsuka America Pharmaceutical, Inc. | 9 | $155 |
| Astellas Pharma US Inc | 4 | $95 |
| GSK | 5 | $94 |
| Merck | 4 | $81 |
| Alk-abello, Inc | 3 | $73 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $60 |
| Boehringer Ingelheim | 3 | $55 |
| Neurocrine Biosciences, Inc. | 2 | $51 |
| Mylan Specialty L.p. | 2 | $50 |
| Abbott | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Bayer | 1 | $16 |
| Amgen | 1 | $14 |
How this compares
$2,936 in reported general payments places this provider in the 85th percentile of 142 primary care providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 43 | $38,904 |
| EliquisApixaban | 20 | $30,404 |
| FarxigaDapagliflozin Propanediol | 23 | $25,329 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $22,963 |
| XareltoRivaroxaban | 14 | $13,179 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $4,990 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $1,902 |
| SynthroidLevothyroxine Sodium | 22 | $1,527 |
| PaxlovidNirmatrelvir/Ritonavir | 16 | $1,429 |
| Levothyroxine Sodium | 133 | $1,338 |
| Atorvastatin Calcium | 154 | $1,256 |
| Rosuvastatin Calcium | 132 | $1,144 |
| Gabapentin | 86 | $1,143 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 52 | $1,062 |
| Celecoxib | 16 | $925 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $219 | $38,90443 claims |
| PfizerEliquis, Paxlovid | $284 | $31,83336 claims |
| AstraZenecaFarxiga, Symbicort | $408 | $30,31937 claims |
| GSKTrelegy Ellipta | $94 | $22,96318 claims |
| AbbVieSynthroid | $598 | $1,52722 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 142 primary care providers in Virginia.
Other primary care in Locust Grove
- Rebecca GrinsellRichmond$12K
- Jennifer CampbellNewport News$8K
- Tien MaAnnandale$7K
- Michael CogginAshland$7K
- Erin StewartFredericksburg$6K
- Lawanda WoodNorfolk$6K
- Sara WeaverDanville$5K
- Luis Rivera PenaFalls Church$4K
- Erika RobinsonFredericksburg$4K
- Haley SwansonVirginia Beach$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.